Total Funding
85
48
Total FundingGrant raised
Growth Score
-1 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
61598
Nanostics is a developer of diagnostics tests intended to diagnose aggressive prostate cancer.
- Colin Coros: CCO
- Robert Paproski: CTO and Co-Founder
About the Company
Nanostics is a developer of diagnostics tests intended to diagnose aggressive prostate cancer.The company's technology combines a sensitive extracellular vesicle detection platform with advanced machine learning to diagnose disease and predict clinically significant prostate cancer from a simple blood test, enabling healthcare professionals to
provide clarity to patients about their health by enabling better diagnosis and improving health care decisions.
